Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus (HIV) Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Not applicableUnknownNCT04482010
What this trial is testing

ANRS 12392 Sanu Gundo

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 265
Not applicableStudy completedNCT04033120
What this trial is testing

Making an Early Diagnosis of Talaromycosis Using a Novel Antigen Test

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDS
Duke University 1,411
Not applicableStudy completedNCT00000915
What this trial is testing

An HIV Vaccine Preparedness Study

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 4,892
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Testing effectiveness (Phase 2)Study completedNCT00213018
What this trial is testing

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

Who this might be right for
HIV InfectionsChlamydia TrachomatisNeisseria Gonorrhoeae+2 more
Population Council 400
Large-scale testing (Phase 3)Study completedNCT00162682
What this trial is testing

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 716
Not applicableStudy completedNCT00002076
What this trial is testing

Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Post-approval studies (Phase 4)Study completedNCT02477527
What this trial is testing

Atripla to Stribild Switch Study to Evaluate Sleep Disturbances

Who this might be right for
HIVAIDSSleep Disorders
Midtown Medical Center, Tampa, FL 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06411223
What this trial is testing

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Who this might be right for
Hiv
Yale University 50
Not applicableStudy completedNCT02116179
What this trial is testing

DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients

Who this might be right for
Human Immunodeficiency VirusAcquired Immunodeficiency SyndromeHepatitis C
University of Delaware 201
Not applicableStudy completedNCT00100646
What this trial is testing

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Who this might be right for
HIV Infections
The Wistar Institute 30
Testing effectiveness (Phase 2)Study completedNCT00081588
What this trial is testing

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 555
Not applicableStudy completedNCT03254550
What this trial is testing

PrEP Demonstration Study in Swaziland

Who this might be right for
HIV Negative People Identified at Substantial Risk for HIV Infection
Clinton Health Access Initiative Inc. 517
Post-approval studies (Phase 4)Ended earlyNCT01367210
What this trial is testing

Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Who this might be right for
HIV Infection
Catholic University of the Sacred Heart 165
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT07629310
What this trial is testing

To Evaluate the Safety of JL18008

Who this might be right for
HIV Infections
Jecho Biopharmaceuticals Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00000820
What this trial is testing

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 104
Not applicableLooking for participantsNCT07725042
What this trial is testing

Analyses of Newly Diagnosed HIV Infection in Hong Kong

Who this might be right for
HIV -1 Infection
Chinese University of Hong Kong 720
Next Page